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Abstract
Background: Spotted fever is a tick-borne rickettsial disease. In Brazil, its notification to the Ministry of Health is
compulsory. Since 2007, cases of spotted fever have been integrated to the Notifiable Diseases Information System,
and epidemiological analyzes are part of the routines on surveillance programs.
Methods: This descriptive study updates epidemiological information on cases of spotted fever registered in Brazil
between 2007 and 2015.
Results: In Brazil, 17,117 suspected cases of the disease were reported and 1,245 were confirmed in 12 states,
mainly in São Paulo (550, 44.2 %) and Santa Catarina (276, 22.2 %). No geographic information was registered for
132 cases (10.6 %). Most of the infected people were men (70.9 %), mainly in rural areas (539, 43.3 %), who had
contact with ticks (72.7 %). A higher number of suspected cases were registered between 2011 and 2015, but the
number of confirmed cases and the incidence were relatively low. Moreover, 411 deaths were registered between
2007 and 2015, mainly in the southeastern region of the country, where the case-fatality rate was 55 %. Lack of
proper filling of important fields of notification forms was also observed.
Conclusions: The results showed expansion of suspected cases of spotted fever and high case-fatality rates, which
could be related to diagnostic difficulties and lack of prompt treatment. These factors may comprise limitations to
the epidemiological surveillance system in Brazil, hence improvement of notification and investigation are crucial to
reduce morbidity and mortality due to spotted fever in Brazil.
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Background
Spotted fever (SF) is an infection caused by gram-
negative, obligate intracellular bacteria of the genus
Rickettsia. The main agent of SF in Brazil is Rickettsia
rickettsii. Nevertheless, other species of Rickettsia
associated or not to SF clinical cases have been registered
in several regions of the country [1–3]. Amblyomma ticks
– such as A. sculptum, A. aureolatum and A. ovale – are
the main vectors and their hosts (usually horses, capybaras
and canines) are nonspecific, therefore, they may also
parasitize humans [4, 5]. Rickettsia rickettsii SF is consid-
ered the most lethal rickettsial disease, and the maculo-
papular rash, its characteristic clinical sign, typically
appears on the fifth day of infection [6]. However, it is not
present in all cases. Rash absence interferes with the
differential diagnosis, and R. rickettsii SF may be
confused with other diseases including leptospirosis,
dengue fever, ehrlichiosis, viral rash diseases, other rickett-
sial related diseases from typhus group, etc. [6–8]. More-
over, Rickettsia parkeri strain Atlantic rainforest is present
in several regions of Brazil, causing a milder spotted fever
with characteristic signs (inoculation eschar and lymph-
adenopathy) [1, 2].
SF has been observed in Brazil since 1929, but only in
2001 it was included in the list of diseases of compulsory
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notification (DCN) from the Ministry of Health (MH)
[9, 10]. Since 2014, it has become a disease of com-
pulsory and immediate notification. Consequently,
health professionals are held responsible for reporting
suspected and/or confirmed cases to the municipality,
state and the Brazilian Ministry of Health within
24 h. Cases of SF are registered into the Notifiable
Diseases Information System (SINAN), which aims to
collect, gather and disseminate data on this disease
[11]. Currently, SF is considered an emerging disease
in Brazil due to the increase in diagnosed cases and
expansion of occurrence areas. However, it is still
little known by health professionals and the general
public [12].
Clinical, epidemiological and laboratory aspects must
be considered to confirm cases of SF. Epidemiological
history of suspected cases helps and may lead to a timely
diagnosis supported by laboratory tests [13, 14]. Epi-
demiological studies are necessary to evaluate the dis-
ease behavior over space and time and may help
surveillance programs in Brazil [15]. Thus, this study
updates epidemiological information on cases of SF reg-
istered in Brazil between 2007 and 2015.
Methods
A descriptive epidemiological study was performed
based on cases of spotted fever notified by investigation
forms (IF) available in SINAN between 2007 and 2015.
The database was accessed on March 14th, 2016. Dupli-
cate or inconsistent information (out of the case defin-
ition proposed by the MH) were excluded from the
analysis.
Cases were considered suspected whenever the
individual presented fever, headache, myalgia and his-
tory of tick bites, and/or contact with domestic and/
or wild animals, and/or had been to SF known trans-
mission areas in the last 15 days, and/or presented
maculopapular rash or hemorrhagic manifestations
[13, 14]. Cases were confirmed when signs, symp-
toms and epidemiological history matched the sus-
pect case definition and when infection with
Rickettsia from the spotted fever group (SFG) was
established [13, 14].
The laboratory testing recommended for SF by the
MH consists of serological evidence of a fourfold change
in immunoglobulin G (IgG)-specific antibody titers re-
active to Rickettsia rickettsia SF group antigens by indir-
ect immunofluorescence assay (IFA) between paired
serum samples (one taken in the first week of illness and
a second 2–4 weeks later). Moreover, it is also recom-
mended the detection of R. rickettsia or other SF
group DNA in a clinical sample via amplification of a
specific target by PCR assay, or demonstration of SF
group antigens in a biopsy or autopsy sample by
immunohistochemistry, as well as isolation of R. rickettsia
or other SF group Rickettsia from a clinical sample in
cell culture.
Variables associated with confirmed cases were ana-
lyzed according to the following classification [16]:
 General data of patients about their origin – region
of Brazil, federative unit (FU) of notification and
municipality of infection.
 Individual data – age, gender and ethnic group.
 Clinical data – main signs and symptoms.
 Epidemiological data – related specifically to
exposure risk.
 Treatment – if there was hospitalization, dates of
admission and discharge.
 Specific laboratory data – if there were laboratory
tests.
 Conclusion data – evolution of cases, confirmation
or disposal criterion, location and characteristics of
the probable place of infection.
The annual incidence rates were calculated employing
the total population per studied year obtained from the
Brazilian Institute of Geography and Statistics (IBGE)
[17]. The absolute number of deaths and confirmed
cases of SF were used to calculate the annual case-
fatality rate. Average coefficients of incidence of SF were
calculated for municipalities and states (cases/100,000
inhabitants per year) [17].
A proportion between missing/blank records and
total filled fields was carried out for the observed var-
iables to assess the completeness of forms. It was
based on the inclusion criteria of the confirmed cases,
involving mandatory (dates of notification, investiga-
tion start, first symptoms and case closing), essential
(dates of hospitalization and development of the case)
and conditioned variables (dates of hospitalization,
discharge and death).
SINAN parameters were used to evaluate the com-
pleteness of data: excellent > 90 %, regular = 70–89 %
and bad < 70 % of the filled fields. Timeliness was calcu-
lated using the difference in days between the intervals
between the following dates: notification and investiga-
tion, notification and closing, the first symptoms and
hospitalization, the first symptoms and discharge, the
first symptoms and death.
The software TabWin 32 version 3.6 [18] was used
for data tabulation, Microsoft Office Excel 2010 for
charts and graphs, and TerraView version 3.2.0.1 for
maps [19]. Secondary data was used in accordance
with the National Health Council Resolution 466/
2012 and does not cover information that could
identify individuals registered in the information
system [20].
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Results
Between 2007 and 2015, 17,117 suspected cases of spot-
ted fever were reported and 1,245 were confirmed in 12
states: São Paulo (n = 550, 44.2 %), Santa Catarina (n =
276, 22.2 %), Minas Gerais (n = 104, 8.5 %), Rio de
Janeiro (n = 90, 7.2 %), Espírito Santo (n = 32, 2.5 %),
Paraná (n = 25, 2.0 %), Ceará (n = 11, 0.9 %), Rio Grande
do Sul (n = 9, 0.7 %), Goiás (n = 7, 0.5 %), Bahia (n = 4,
0.3 %), Mato Grosso do Sul (n = 4, 0.3 %) and Rondônia
(n = 1, 0.1 %). No geographic information was registered
for 132 cases of SF (10.6 %). Between 2007 and 2009, the
number of reported cases decreased, but in the following
years, there was an increase in the number of notifica-
tions (Fig. 1).
The highest incidence rates were observed in Santa
Catarina (0.48/100,000 inhabitants) and São Paulo
(0.14/100,000 inhabitants) states. Higher incidences
were also observed in the municipalities of Rodeio,
Corupá and Luiz Alves (14.3, 13.9, and 13.8 respect-
ively) (Fig. 2). Most infected people were white males
between 20 and 64 years of age, from rural areas and
who had contact with ticks (Table 1). Deaths were
more frequent in males (79.1 %) than females
(Table 1). Females had home as the primary site of
infection acquisition (210/321, 65.4 %) while males
probably acquired infection during leisure activities
(239/779, 30.6 %).
The majority of SF patients had visited environments
such as forests, rivers and waterfalls (66.7 %) and were
exposed to ticks (72.7 %). Other animals such as capy-
baras (15.6 %), dogs and cats (42.4 %), cattle (17.2 %)
and horses (17.4 %) were also reported in the investiga-
tion forms of confirmed cases. A higher incidence rate
was observed between September and November (41 %).
A total of 207 cases of SF (16.6 %) were registered in
October.
A total of 411 deaths were registered resulting in an
overall case-fatality rate of 33 %. The southeastern
region showed the highest case-fatality rate (55 %). An
increase of 57.9 % of deaths was observed in the last
years (Fig. 1). Among confirmed cases, 760 (61 %) were
hospitalized, of which 391 died, representing a case-
fatality rate of 51.4 % (Table 1).
Laboratory criteria was the most used in the study
period (n = 1,223, 90.2 %) then clinical and epidemio-
logical 103 (8.2 %). The main SF signs and symptoms
reported were fever, headache, myalgia, prostration and
nausea/vomiting that had a different distribution among
Brazilian regions (Fig. 3).
Although most information was available in the notifi-
cation forms, the discharge date and date of death were
the questions less answered (Table 2). Hospitalization
date and progression of cases received more responses
and were rated as excellent.
Discussion
An increase in the number of suspected cases of SF was
observed between 2007 and 2015; however, the number
of confirmed cases presented low variation. High case-
fatality rates were registered in southeastern Brazil.
South and Southeast regions had the highest inci-
dence rates, with most cases being reported in São
Paulo and Santa Catarina, a finding corroborated by
Barros-Silva et al. [21]. Moreover, the present study
shows the first cases of SF in the states of Mato
Grosso do Sul and Rondônia, where Rickettsia species
were already found in ticks [22, 23]. These results
show an expansion of SF in Brazil.
The incorporation of molecular diagnostic tech-
niques by the MH in 2011 increased the number of
deaths attributable to SF in Brazil, which could ex-
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Fig. 1 Absolute number of reported cases, confirmed ones and deaths due to spotted fever and annual case-fatality rate between 2007
and 2015 in Brazil
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present study [13, 14]. Such techniques allowed the
identification of suspected cases that progressed to
death without diagnosis using a unique sample. The
present work also included records of deaths in
southern Brazil, in transition areas within the state of
São Paulo, which indicates the possible occurrence of
Rickettsia rickettsia. This situation comprises a threat
to public health and highlights the need for research
on the strains occurring in these regions. Increase in
the number of notifications is a result of efforts pro-
moted by the MH, which is developing continuous
training processes and educational activities aimed at
structuring a network for surveillance of spotted fever
and other rickettsial diseases in the country [24].
In the United States of America, a public health sys-
tem (TickNET) promotes surveillance, research, educa-
tion and prevention of tick-borne diseases. Nevertheless,
notification of cases is not mandatory. In that country,
cases are reported under a category called spotted fever
rickettsiosis [25–27]. Since the 1930s, countries in the
Americas, such as Colombia and Mexico, began to regis-
ter focal cases of rickettsial diseases as fiebre de tobia
and fiebre manchada, respectively. However, these re-
cords are collected by research centers and public infor-
mation is not provided.
The present findings show that most of the confirmed
victims were males, which is in agreement with inter-
national reports of the Centers for Disease Control and
Prevention and the European Center for Disease Preven-
tion and Control [26, 28]. In Brazil, men were infected
in leisure activities whereas women become infected in
household chores [29]. The most affected ethnic group
in Brazil was white people, especially in the Southeast
and South. However, rash is not easily seen in black
complexion and this could be hindering the diagnosis of
SF cases in this ethnic group [30].
Fig. 2 Geographical distribution of confirmed cases of spotted fever by federative unit (FU) and average incidence rate in affected municipalities
between 2007 and 2015
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The highest incidence was observed in rural areas in
individuals who visit forest areas, rivers and waterfalls.
Souza et al. [31] reported a high SF incidence in urban
areas in São Paulo. The same study also suggested that
SF transmission is related to the existence of a dirty pas-
ture environment where A. sculptum ticks and capybaras
are present. Although the findings by Souza et al.
[31] indicated no relationship between SF and work
activities, there is an outbreak record mentioning
cases of SF in an animal shelter, which suggests a risk
of occupational exposure [32]. Such situation draws
attention to the need of preventive practices for pro-
fessionals engaged in activities that may pose risks for
rickettsial infections [33].
Contact with ticks was registered in 72 % of investiga-
tion forms. Amblyomma cajennense tick complex has a
wide distribution in Brazil [5]. Szabó et al. [4] empha-
sizes that although Rhipicephalus sanguineus tick is
present throughout Brazil, its participation in epidemic
cycles has not been definitively proven. Most cases of SF
were registered in October, when a higher density of
vectors (tick nymphs) is recorded, which may be associ-
ated with transmission to humans [34]. However, climate
variations should be examined promptly within munici-
palities and Brazilian ecoregions.
The majority of the confirmed cases required
hospitalization. Southeast was the region that had more
records of cases and deaths. R. rickettsii have poten-
tial for the development of serious forms of the dis-
ease, with systemic disorders such as respiratory
failure, oliguria, hemorrhagic manifestations, neuro-
logical changes and shock. High case-fatality rates
may be associated with [29]:
 A low index of suspicion per health care
professionals.
 Lack of knowledge on the clinical features of the
disease, which is often confused with other
infections that have similar symptoms such as
dengue and leptospirosis.
Table 1 Absolute number and percentage of confirmed
spotted fever cases and deaths regarding probable area of
infection, relation to work, exposure to risk environments
and hospitalization, between 2007 and 2015 in Brazil
Cases Deaths
N % N %
Gender
Male
<1 year 4 0.45 2 0.61
1–4 years 20 2.26 8 2.46
5–9 years 49 5.54 15 4.61
10–14 years 46 5.20 18 5.53
15–19 years 56 6.34 22 6.76
20–49 years 445 50.39 151 46.46
50–64 years 209 23.66 82 25.23
65–79 years 53 6 27 8.30
>80 years 1 0.11 0 0
Female
<1 year 5 1.38 1 1.16
1–4 years 27 7.45 6 6.97
5–9 years 27 7.45 10 11.62
10–14 years 31 8.56 12 13.95
15–19 years 20 5.52 5 5.81
20–49 years 183 50.55 37 43.02
50–64 years 53 14.64 12 13.95
65–79 years 15 4.14 3 3.48
>80 years 1 0.27 0 0
Ethnic Group
White 816 65.54 220 53.53
Black 56 4.5 32 7.79
Asian 7 0.56 0 0
Multiracial 215 17.27 90 21.9
Indigenous 4 0.32 1 0.24
Missing/blank 147 11.81 68 16.55
Probable area of infection
Rural 539 43.29 146 35.52
Urban 407 32.69 139 33.82
Periurban 173 13.90 70 17.03
Missing/Blank 126 10.12 56 13.63
Work-related transmission
Yes 213 17.11 63 15.33
No 860 69.08 264 64.23
Missing/blank 182 14.62 84 20.44
Exposure to risk environments
Yes 831 66.75 254 61.80
No 255 20.48 64 15.57
Missing/blank 159 12.77 93 22.63
Table 1 Absolute number and percentage of confirmed
spotted fever cases and deaths regarding probable area of
infection, relation to work, exposure to risk environments
and hospitalization, between 2007 and 2015 in Brazil
(Continued)
Hospitalization
North 9 0.72 1 0.24
Northeast 1 0.08 0 0
Southeast 615 49.39 336 81.75
South 37 2.97 4 0.97
Central-West 6 0.48 1 0.24
Missing/blank 92 7.38 49 11.92
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 Eco-epidemiological aspects associated with the risk
of infection.
 Risk factors for exposure to the vector in
transmission areas of the disease.
In southern Brazil, the disease is milder and most
cases do not require hospitalization. This fact may be
associated with infections caused by R. parkeri – an
Atlantic rainforest strain that leads to a benign evolution
[35]. However, in the north of Paraná, fatal cases of the
disease provoked by R. rickettsii were observed [16].
Laboratory tests were used for confirmation of the
majority of the cases. The most commonly used is the
serologic one that verifies IgM and IgG titers without
specifically checking the species of the etiologic agent,
which is one of the current limitations of laboratory
diagnosis in Brazil. According to Labruna et al. [3], there
are different species of Rickettsia of the spotted fever
group in Brazil (Rickettsia rickettsii, R. parkeri, R. felis,
R. rhipicephali, R. bellii, R. typhi, R. amblyommii, R.
andeane and R. monteiroi), many of those with unknown
pathogenicity.
The most frequent clinical signs were fever, headache
and myalgia. The presence of rash, an important sign of
the disease, was recorded in less than 40 % of the con-
firmed cases. It is necessary to assess the current proce-
dures and to consider regional particularities, thus


































North Northeast Southeast South Central West*
Fig. 3 Main spotted fever signs and symptoms reported to the Notifiable Diseases Information System, by Brazilian region, between 2007 and
2015. *In the North region only one case was reported that presented the following symptoms: nausea/vomiting, prostration, myalgia, fever
and headache
Table 2 Completeness of notification forms for spotted fever in
Brazil (2007–2015) concerning dates of notification of the main




Date of notification 1245 100
First symptoms 1245 100




Course of the case 1197 96.14
Deatha 424 34.05
Closing 1245 100
Timeliness – notification Media (days) Median (days)
Investigation date 16.57 6
Closing date 53.36 40
Timeliness – reporting of first symptoms Media (days) Median (days)
Admission date 7.02 4
Discharge date 16.38 8
Deatha 12.02 6
aDeath due to spotted fever
de Oliveira et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2016) 22:22 Page 6 of 8
seeking to identify signs, symptoms and epidemiological
characteristics that may be related to the Rickettsia spe-
cies. SF caused by R. rickettsii evolves rapidly and with-
out the correct and timely medical interventions, clinical
cases can develop to severe clinical forms, such as
icterus, seizures, hemorrhagic suffusion and extremity
necrosis. Further studies should evaluate the burden of
SF, considering the impact of deaths of children, young
people and adults in working age, as well as amputations
resulting from necrotic processes and other sequels. All
these injuries generate loss of life years, disability, eco-
nomic costs to the health system and social security, sick
leaves and pensions.
In 2013, the treatment protocol for cases of spotted
fever was revised in Brazil, adding new recommenda-
tions, with emphasis on use of doxycycline as the first
choice medication, regardless of age. The Ministry of
Health of Brazil started to provide these drugs in stra-
tegic places in endemic areas [36]. Future evaluations of
the effectiveness of these new treatment guidelines on
case-fatality rates will be required.
The main limitation of this study is the underreporting
of cases to epidemiological surveillance systems. The
addition of other databases of the Brazilian health sys-
tem in future analysis – such as those from hospitals,
laboratories and mortality information system – would
certainly quantify new cases of SF. Low completeness may
also interfere with results of studies based on SINAN da-
tabases. Regarding confirmed cases, there was complete
filling of the notification dates, early symptoms, early re-
search and closing date of the cases. These fields are cru-
cial for understanding the quality of health care in cases of
SF. Timeliness – which was analyzed between admission,
discharge and death – demonstrated a rapid clinical
course and the need to rapidly identify cases and take the
appropriate treatment in order to reduce case-fatality rate.
Conclusions
The results showed expansion of suspected cases of spot-
ted fever and high case-fatality rates, which could be re-
lated to diagnostic difficulties and lack of prompt
treatment. These factors may be limitations of the SF Epi-
demiological Surveillance System in Brazil, hence im-
provement of notification and investigation are crucial for
to reduce morbidity and mortality due to SF in Brazil.
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